- /
- Supported exchanges
- / US
- / KVUE.NYSE
Kenvue Inc. (KVUE NYSE) stock market data APIs
Kenvue Inc. Financial Data Overview
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Kenvue Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Kenvue Inc. data using free add-ons & libraries
Get Kenvue Inc. Fundamental Data
Kenvue Inc. Fundamental data includes:
- Net Revenue: 15 292 M
- EBITDA: 3 470 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: 0.26
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kenvue Inc. News
New
Kenvue (KVUE) Stock May Be A Bargain Despite The Acquisition Bid
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Kenvue stock has climbed 14.5% over the past month, yet there is a clear split ...
Kenvue (KVUE) Faces A $48.7 Billion Kimberly Clark Deal And Big Portfolio Questions
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Kimberly-Clark has announced a planned $48.7b acquisition of Kenvue (NYSE:KVUE). The transa...
hould You Buy Kenvue Inc. (KVUE)’s Shares?
Kenvue Inc. (NYSE:KVUE) is one of the 10 Best Stocks to Buy According to Billionaire Glenn Dubin's Highbridge Capital. Consumer health company Kenvue Inc. (NYSE:KVUE)'s shares are down by 8.8% over t...
Kimberly-Clark’s 80% Payout Ratio: Balance Sheet Says Retirees Shouldn’t Be Scared
Quick Read KMB's dividend looks stressed at 0.99x FCF coverage, but Q1 2026 operating cash flow surged 128% while the balance sheet deleveraged sharply from 9x to 5x debt-to-equity. KMB's $48.7B acqu...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.